Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001558370-18-004151
Filing Date
2018-05-07
Accepted
2018-05-07 16:16:09
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B3 f424b3.htm 424B3 1373563
2 GRAPHIC f424b3g001.jpg GRAPHIC 17673
3 GRAPHIC f424b3g002.gif GRAPHIC 83465
4 GRAPHIC f424b3g003.jpg GRAPHIC 140873
5 GRAPHIC f424b3g004.gif GRAPHIC 57015
  Complete submission text file 0001558370-18-004151.txt   1786924
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-222738 | Film No.: 18811412
SIC: 3841 Surgical & Medical Instruments & Apparatus